Newsletter | October 12, 2026

10.12.26 -- Why Oncology Programs Can't Rely On An Inside View Alone

PATIENT CENTRICITY

 

Why Oncology Programs Can't Rely On An Inside View Alone

Discover how looking outside a program can help oncology teams test assumptions, improve feasibility, and make stronger development decisions.

 

What Re-Acquisition In Retinal Imaging Is Really Costing Your Program

High screen failure rates and patient dropout often stem from preventable imaging errors. Learn how proactive quality control and patient-centric logistics secure critical retinal trial data.

 

Inside Home Trial Support: Safety, Logistics, And The Patient Experience

Discover how MRN’s CEO Stuart Redding leads efforts to bring clinical trials to patients' homes, workplaces, and communities, enhancing accessibility across all trial phases.

 

Listen To Your Trial Participants — Your Research Depends On It

Clinical research advances through participant insights. A patient-centered platform streamlines operations, enabling real-time feedback and communication to improve engagement and study outcomes.

PATIENT RECRUITMENT

 

Most Patients Learn About A Trial Online, But Is That What They Want?

Patients want to hear about clinical trials from their doctors — but most learn out online. CISCRP explores how industry can change the referral pathway for better.

 

4 Proven Strategies To Optimize Patient Enrollment, Avoid Rescue Trials

Though rescue studies are common, there are ample tactics to avoid these situations altogether, including robust planning, data analysis, and prioritization of patient recruitment and retention.

 

Patient Intelligence

Building a full patient picture means finding data on where eligible patients are, how they are treated & how they can be reached. Citeline’s Patient Intelligence connects those insights in one view.

 

What Does 'Powered By Block Clinical' Mean?

Join us in supporting every part of the clinical trial ecosystem — patients, caregivers, sites, and suppliers — to ensure trials run safely, efficiently, and successfully.

CLINICAL SITES

 

How A $96M Gift Is Transforming Pediatric Brain Cancer Clinical Trial Infrastructure

By pairing donor priorities with research needs at Children's National, Milken Institute SPARC is turning philanthropy into faster trials, stronger infrastructure, and long-term care goals.

 

Participant Support Exists. Are Sites Able To Use It?

Participant support can exist without being consistently used. Explore why site adoption, workflow fit, and continued access deserve attention throughout the life of a clinical study.

 

Traversing Complexity In Breast Cancer Clinical Development

Biomarkers, new therapies, and tough enrollment hurdles are reshaping breast cancer trials. Get the insights to plan smarter.

 

Frequently Asked Questions About Travel For Clinical Trial Patients

Find answers to the most common questions about trial travel support, from booking rides to arranging complex logistics for caregivers and patients.

Connect With Clinical Leader: